CALCIMEDICA INC (CALC) Fundamental Analysis & Valuation

NASDAQ:CALC • US38942Q2021

Current stock price

0.52 USD
-0.05 (-8.61%)
At close:
0.528 USD
+0.01 (+1.54%)
Pre-Market:

This CALC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. CALC Profitability Analysis

1.1 Basic Checks

  • CALC had negative earnings in the past year.
  • In the past year CALC has reported a negative cash flow from operations.
  • In the past 5 years CALC always reported negative net income.
  • CALC had a negative operating cash flow in each of the past 5 years.
CALC Yearly Net Income VS EBIT VS OCF VS FCFCALC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 -10M -20M -30M -40M

1.2 Ratios

  • With a Return On Assets value of -217.51%, CALC is not doing good in the industry: 88.54% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -217.51%
ROE N/A
ROIC N/A
ROA(3y)-189.56%
ROA(5y)-142.04%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CALC Yearly ROA, ROE, ROICCALC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 2025 0 200 -200 400 -400

1.3 Margins

  • CALC does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CALC Yearly Profit, Operating, Gross MarginsCALC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 2025

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. CALC Health Analysis

2.1 Basic Checks

  • Compared to 1 year ago, CALC has more shares outstanding
  • CALC has more shares outstanding than it did 5 years ago.
  • CALC has a worse debt/assets ratio than last year.
CALC Yearly Shares OutstandingCALC Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M
CALC Yearly Total Debt VS Total AssetsCALC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

2.2 Solvency

  • CALC has an Altman-Z score of -24.01. This is a bad value and indicates that CALC is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -24.01, CALC is doing worse than 86.46% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -24.01
ROIC/WACCN/A
WACCN/A
CALC Yearly LT Debt VS Equity VS FCFCALC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M 60M 80M

2.3 Liquidity

  • A Current Ratio of 3.58 indicates that CALC has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 3.58, CALC is in line with its industry, outperforming 57.29% of the companies in the same industry.
  • A Quick Ratio of 3.58 indicates that CALC has no problem at all paying its short term obligations.
  • With a Quick ratio value of 3.58, CALC perfoms like the industry average, outperforming 59.90% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.58
Quick Ratio 3.58
CALC Yearly Current Assets VS Current LiabilitesCALC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. CALC Growth Analysis

3.1 Past

  • CALC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -63.41%.
EPS 1Y (TTM)-63.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-92.11%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • Based on estimates for the next years, CALC will show a decrease in Earnings Per Share. The EPS will decrease by -3.23% on average per year.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y20.33%
EPS Next 2Y-3.23%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CALC Yearly Revenue VS EstimatesCALC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2027 2028 5M 10M 15M 20M 25M
CALC Yearly EPS VS EstimatesCALC Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 -10 -20 -30 -40 -50

More info and screens

Find the best growth stocksShow best growing peers

0

4. CALC Valuation Analysis

4.1 Price/Earnings Ratio

  • CALC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CALC. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CALC Price Earnings VS Forward Price EarningsCALC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CALC Per share dataCALC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share -0.5 -1 -1.5 -2

4.3 Compensation for Growth

  • CALC's earnings are expected to decrease with -3.23% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-3.23%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CALC Dividend Analysis

5.1 Amount

  • CALC does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CALC Fundamentals: All Metrics, Ratios and Statistics

CALCIMEDICA INC

NASDAQ:CALC (3/30/2026, 8:00:02 PM)

Premarket: 0.528 +0.01 (+1.54%)

0.52

-0.05 (-8.61%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)03-03
Earnings (Next)05-12
Inst Owners47.54%
Inst Owner Change3.02%
Ins Owners18.57%
Ins Owner Change0%
Market Cap8.18M
Revenue(TTM)N/A
Net Income(TTM)-29.56M
Analysts82
Price Target10.54 (1926.92%)
Short Float %3.57%
Short Ratio0.27
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-48.54%
Min EPS beat(2)-73.5%
Max EPS beat(2)-23.59%
EPS beat(4)0
Avg EPS beat(4)-31.06%
Min EPS beat(4)-73.5%
Max EPS beat(4)-12.04%
EPS beat(8)3
Avg EPS beat(8)0.73%
EPS beat(12)5
Avg EPS beat(12)-245.11%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-24.39%
PT rev (3m)-36.41%
EPS NQ rev (1m)45.1%
EPS NQ rev (3m)45.1%
EPS NY rev (1m)0%
EPS NY rev (3m)12.29%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-2.01
EYN/A
EPS(NY)-1.6
Fwd EYN/A
FCF(TTM)-1.35
FCFYN/A
OCF(TTM)-1.35
OCFYN/A
SpS0
BVpS-0.42
TBVpS-0.42
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -217.51%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-189.56%
ROA(5y)-142.04%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 60.87%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.58
Quick Ratio 3.58
Altman-Z -24.01
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)69.72%
Cap/Depr(5y)78.91%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-63.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-92.11%
EPS Next Y20.33%
EPS Next 2Y-3.23%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y4.47%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-23.69%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-0.25%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-0.15%
OCF growth 3YN/A
OCF growth 5YN/A

CALCIMEDICA INC / CALC Fundamental Analysis FAQ

What is the ChartMill fundamental rating of CALCIMEDICA INC (CALC) stock?

ChartMill assigns a fundamental rating of 1 / 10 to CALC.


Can you provide the valuation status for CALCIMEDICA INC?

ChartMill assigns a valuation rating of 0 / 10 to CALCIMEDICA INC (CALC). This can be considered as Overvalued.


What is the profitability of CALC stock?

CALCIMEDICA INC (CALC) has a profitability rating of 0 / 10.


What is the earnings growth outlook for CALCIMEDICA INC?

The Earnings per Share (EPS) of CALCIMEDICA INC (CALC) is expected to grow by 20.33% in the next year.